Buy KBL Merger Corp. Stock | KBLM Stock Price & Latest News | Public.com
KBLM

KBL Merger Corp.

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View KBL Merger Corp. (KBLM) stock trends here

    About KBLM

    180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Stats

    Market Cap$21,64M
    Volume406,23k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$11.50
    1 Year Low$1.90
    Open$4.05
    High$4.09
    Low$3.51

    Buy any stock with any amount of money.

    Download the App
    Download the app